1. Home
  2. SER vs BRIA Comparison

SER vs BRIA Comparison

Compare SER & BRIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SER
  • BRIA
  • Stock Information
  • Founded
  • SER 2017
  • BRIA 2011
  • Country
  • SER United States
  • BRIA Singapore
  • Employees
  • SER N/A
  • BRIA N/A
  • Industry
  • SER Biotechnology: Pharmaceutical Preparations
  • BRIA
  • Sector
  • SER Health Care
  • BRIA
  • Exchange
  • SER Nasdaq
  • BRIA NYSE
  • Market Cap
  • SER 53.5M
  • BRIA 47.1M
  • IPO Year
  • SER 2018
  • BRIA 2024
  • Fundamental
  • Price
  • SER $5.80
  • BRIA $2.62
  • Analyst Decision
  • SER Strong Buy
  • BRIA
  • Analyst Count
  • SER 1
  • BRIA 0
  • Target Price
  • SER $11.00
  • BRIA N/A
  • AVG Volume (30 Days)
  • SER 12.2K
  • BRIA 31.3K
  • Earning Date
  • SER 05-24-2025
  • BRIA 05-15-2025
  • Dividend Yield
  • SER N/A
  • BRIA N/A
  • EPS Growth
  • SER N/A
  • BRIA N/A
  • EPS
  • SER N/A
  • BRIA 92.24
  • Revenue
  • SER $56,000.00
  • BRIA $59,695,825.00
  • Revenue This Year
  • SER N/A
  • BRIA N/A
  • Revenue Next Year
  • SER N/A
  • BRIA N/A
  • P/E Ratio
  • SER N/A
  • BRIA $0.03
  • Revenue Growth
  • SER N/A
  • BRIA 8.03
  • 52 Week Low
  • SER $3.81
  • BRIA $1.78
  • 52 Week High
  • SER $14.57
  • BRIA $4.38
  • Technical
  • Relative Strength Index (RSI)
  • SER 55.22
  • BRIA N/A
  • Support Level
  • SER $5.12
  • BRIA N/A
  • Resistance Level
  • SER $6.61
  • BRIA N/A
  • Average True Range (ATR)
  • SER 0.49
  • BRIA 0.00
  • MACD
  • SER -0.01
  • BRIA 0.00
  • Stochastic Oscillator
  • SER 56.45
  • BRIA 0.00

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

About BRIA BRILLIA INC

BrilliA Inc is engaged in business of sales and marketing of lingerie's products including bra, panty and body suit, mainly serving the American, European and other markets.

Share on Social Networks: